| Literature DB >> 20827501 |
Paola Secchiero1, Federica Corallini, Barbara Zavan, Claudio Tripodo, Vincenzo Vindigni, Giorgio Zauli.
Abstract
A disseminated model of non-Hodgkin's lymphoma with prevalent liver metastasis was generated by intraperitoneal (i.p.) injection of EBV(+) B lymphoblastoid SKW6.4 in nude-SCID mice. The survival of SKW6.4 xenografts (median survival = 27 days) was significantly improved when hyaluronan scaffolds embedded with mesenchimal stem cells (MSC) were implanted in the abdominal area 4 days after SKW6.4 injection (median survival = 39.5 days). Mice implanted with MSC showed a significant improvement of hepatic functionality in lymphoma xenografts, as demonstrated by measurement of serum ALT/AST levels. Co-culture of MSC with lymphoma cells enhanced the release of hepatocyte growth factor (HGF) by MSC. These data suggest that hyaluronan-embedded MSC exert anti-lymphoma activity by ameliorating hepatic functionality.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20827501 DOI: 10.1007/s10637-010-9534-z
Source DB: PubMed Journal: Invest New Drugs ISSN: 0167-6997 Impact factor: 3.850